Augmenting Clinical Workflow With a Structured Chatbot for Patient History Collection and Diagnostic Support (CHAT-HX)
Prospective Observational Evaluation of a Structured, Agentic AI Chatbot for Pre-Visit Patient History Collection and Diagnostic Support in Outpatient Clinical Workflows
Doctors spend much of each visit collecting the patient's medical history, and incomplete histories can delay diagnosis. This study tests an AI chatbot that interviews patients before their appointment and produces a structured summary of their history for the doctor. Adult patients at the first study site, a university gynecology outpatient clinic in Germany, answer the chatbot's questions on a tablet before the doctor visit. The doctor then takes the history and examines the patient as usual, without seeing the chatbot's output. Only after the doctor has finished planning care does the doctor review the chatbot's summary and rate its usefulness and accuracy. The chatbot does not change patient care. Patients also rate the ease of use and acceptability of the chatbot. The investigators will report how useful doctors find the summaries, how complete and correct the summaries are, and how patients experience the tool.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This is a prospective, observational study of an AI-based, structured history-taking tool used before a clinical visit. The tool uses large language models and follows a fixed interview plan with defined topic blocks, such as chief complaint, current history, past conditions, medications, allergies, specialty-specific history, and social and family history. It produces a structured history summary, a list of possible diagnoses, and suggested workup steps. In earlier benchmarking on more than 670 simulated and clinical cases, the system captured most clinically relevant history items and flagged clinically important warning signs.
The study is designed so that the tool does not influence care. Participants give written informed consent, then complete the AI interview on a study tablet using a pseudonymous study ID. Participants enter no name, birth date, or address. Participants then complete a short questionnaire on usability and acceptance. The treating physician takes a full history, examines the patient, and documents a plan without access to the AI output. Only afterward does the physician receive the AI output and complete a structured evaluation of its completeness, correctness, plausibility, and usefulness. No follow-up contact occurs after the visit.
The study is not randomized and has no control arm. The physician's independently obtained history serves as the reference standard. The first site is the Department of Gynecology at Leipzig University Hospital, with about 100 patients and 8 to 15 physicians. Analysis is descriptive, with subgroup comparisons by reason for visit. Additional sites may be added later. The study is a collaboration between Leipzig University Hospital and Massachusetts General Hospital and Harvard Medical School.
Studietype
Inschrijving (Geschat)
Contacten en locaties
Studiecontact
- Naam: Sonu Subudhi, MBBS, PhD
- Telefoonnummer: 617-726-8051
- E-mail: ssubudhi@mgh.harvard.edu
Studie Locaties
-
-
-
Leipzig, Duitsland, 04103
- Universität Leipzig
-
Contact:
- Bahriye Aktas
- Telefoonnummer: +49 341 97 23400
- E-mail: bahriye.aktas@medizin.uni-leipzig.de
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Adult women presenting for the first time, or with a new complaint, to the general gynecology outpatient clinic, the gynecology emergency clinic, or as referrals to the gynecology outpatient clinic at the first study site (Leipzig University Hospital, Germany). Patients are recruited consecutively in the clinic waiting area by trained study staff. Additional sites may be added later.
Beschrijving
Inclusion Criteria:
Women 18 years or older
First presentation or new complaint at the gynecology outpatient clinic (self-presentation, emergency, or referral)
Sufficient German language skills to complete a structured patient interview independently
Able to complete study participation without external support
Written informed consent
Exclusion Criteria:
Acute emergency requiring immediate treatment (for example, impaired consciousness, hemodynamic instability, or acute bleeding requiring immediate care)
Lack of legal or decisional capacity to consent
Insufficient language skills
Severe cognitive, visual, or motor impairment preventing tablet use
Previous participation in this study
Refusal or withdrawal of consent
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Observatiemodellen: COHORT
- Tijdsperspectieven: PROSPECTIVE
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Adult Clinic Patients
Adult patients with a first presentation or new complaint at the participating outpatient clinic who consent to complete the AI-based pre-visit history interview and questionnaire. Their physician completes routine care blinded to the AI output, then evaluates the AI-generated summary. |
A large language model-based agentic chatbot that conducts a structured, pre-visit history interview on a study tablet and generates a history summary, differential diagnosis list, and workup suggestions. The output is released to the treating physician only after the physician has completed an independent history, examination, and care plan, and does not influence patient care. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Proportion of AI history summaries rated useful by the evaluating physician
Tijdsspanne: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
After completing routine care, the treating physician rates the usefulness of the AI-generated history summary on a 5-point Likert scale (1 = not useful at all, 5 = very useful). The outcome is the proportion of summaries rated 4 or higher, reported with a 95% Wilson confidence interval. |
Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Completeness of the AI-generated history
Tijdsspanne: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Percentage of items from a standardized history grid that the AI captured correctly, reported overall and by history domain. |
Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
|
Correctness of the AI-generated history
Tijdsspanne: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Proportion of factually incorrect or missing clinically relevant items in the AI history, per physician review. |
Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
|
Plausibility of AI differential diagnoses
Tijdsspanne: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Physician rating of plausibility on a 1-5 Likert scale, and concordance of the AI differential with the physician's working diagnosis. |
Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
|
Plausibility of AI workup recommendations
Tijdsspanne: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Physician rating of the AI's suggested diagnostic workup on a 1-5 Likert scale. |
Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
|
Identification of clinically relevant red flags
Tijdsspanne: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Proportion of clinically relevant red flags correctly recognized by the AI versus not recognized, per physician review. |
Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
|
Patient usability (System Usability Scale)
Tijdsspanne: Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
|
Patient-completed System Usability Scale, score 0-100, higher scores indicating better usability. |
Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
|
|
Patient acceptance and willingness to use the tool again
Tijdsspanne: Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
|
Patient-reported acceptance, comprehensibility, empathy, comfort, trust, and willingness to use again, each on a 1-5 Likert scale. |
Same day as the enrollment visit, immediately after the AI interview or after the physician consultation (up to approximately 1 day)
|
|
Duration of the AI interaction
Tijdsspanne: During the AI interview at the enrollment visit (approximately 15 minutes)
|
Time in minutes for the patient to complete the AI interview, recorded automatically by the system. |
During the AI interview at the enrollment visit (approximately 15 minutes)
|
|
Physician-estimated time savings
Tijdsspanne: Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Physician's estimate, in minutes, of the time the AI history would save in clinical workflow. |
Same day as the enrollment visit, after routine care is complete (up to approximately 1 day)
|
Medewerkers en onderzoekers
Sponsor
Medewerkers
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Andere studie-ID-nummers
- 2026P001764
- 201/26-ek (Andere identificatie: Ethics Committee, Medical Faculty, Leipzig University)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
Individual participant data will not be shared with outside researchers. Participants consented under a German ethics-approved form that permits only fully anonymized, aggregated data to be shared with collaborating study partners for analysis and publication. Data are pseudonymized, are classified as health data under GDPR, and remain on servers of the clinical site. De-identified aggregate results will be reported in publications.
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .